This finding indicated that the association between UBE2C overexpression and the survival of patients with HR+/HER2– breast cancer might be estrogen related; thus, in this study, we assessed the effect of estrogen on UBE2C expression using HR+/HER2– breast cancer cells. Here, ERBB2 is linked to breast cancer.